Abstract
Aims To conduct the first cross-sectional epidemiological investigation of pathologic myopia (PM) in UK adults with high myopia.
Methods Fundus photographs of 3,024 highly myopic eyes (spherical equivalent refraction, SER ≤ –5.00D) from 2,000 randomly sampled adults (aged 40-70 years) in the UK Biobank were double graded by an ophthalmic reading centre using the Meta-analysis for Pathologic Myopia framework. Adjudication was performed by one of two retinal specialists. Multivariable mixed-effects logistic regression was used to explore potential risk factors and fundus biomarkers—initially controlling for SER, age and sex, before including all variables with p<0.10 in a single model.
Results PM was present in 1,138 of 3,006 gradable fundus photographs, with 41.7% (95% CI: 39.5%-43.9%) of participants affected in at least one eye graded. Most eyes with PM exhibited diffuse chorioretinal atrophy (97.4%), while the more severe stages— patchy chorioretinal atrophy and macular atrophy—were observed in only 24 and 5 eyes, respectively. Thirteen eyes had “plus” lesions or suspected staphyloma. Factors independently associated with increased odds of PM (all p<0.05) included decreasing SER (adjusted odds ratio: 0.22, 95% CI: 0.15-0.32), older age (2.20, 1.63-2.97), female sex (1.87, 1.12-3.12), lower deprivation (0.73, 0.56-0.94), White ethnicity (52.3, 17.3-158.3), lower retinal arteriovenous ratio (0.47, 0.37-0.58), increased retinal vascular complexity (4.68, 3.22-6.81) and a relatively horizontal disc orientation (2.98, 1.88-4.72). None of the explored modifiable lifestyle or health-related variables were associated with PM.
Conclusions PM prevalence is high among mid-life adults with high myopia in the UK Biobank. Although most cases are mild, the progressive and age-related nature of PM means an elevated risk of irreversible visual impairment for these individuals in later life.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was directly funded by the Medical Research Council (MR/N013166/1 & Flexible Supplement Funds), the Edinburgh Futures Institute, and the Visual Research Trust (SCOO4516). The funders had no role in the design and conduct of this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was conducted using data from the UK Biobank, a major biomedical database, under project ID 90655. As the UK Biobank has prior Research Tissue Bank approval from the Northwest Multi-Center Research Ethics Committee (06/MRE08/65), a separate ethical clearance was not required for the present study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Research Ethics Approval:
This research was conducted using data from the UK Biobank, a major biomedical database, under project ID 90655. As the UK Biobank has prior Research Tissue Bank approval from the Northwest Multi-Center Research Ethics Committee (06/MRE08/65), a separate ethical clearance was not required for the present study.
Competing interests:
The authors declare no competing interests.
Data Availability
Data directly supporting the results of this work are only available to the immediate research team members due to UK Biobank's access control policy. Bona fide researchers can, however, apply for access at ukbiobank.ac.uk/enable-your-research/apply-for-access. Source code used to perform the analysis described in this work is freely available at github.com/fyii200/UKbiobankPM.
https://github.com/fyii200/UKbiobankPM
https://ukbiobank.ac.uk/enable-your-research/apply-for-access
